Digital high-speed imaging systems manufacturer Vision Research has for the first time supplied an embedded Phantom high-speed camera for use within a medical device with U.S. Food and Drug Administration (FDA) 501(k) clearance.
The device, Cytovale’s IntelliSep test, is a new diagnostic tool that provides clinicians with early indication of sepsis probability to support critical time-sensitive clinical decisions, providing test results in under 10 minutes and contributing to rapid life-saving decisions.
The Phantom VEO 710 high-speed camera is a critical component of the IntelliSep test. Source: Vision Research
Critical to this groundbreaking diagnostic system is the Phantom VEO 710 high-speed camera, which resolves blood cells as they move through the microfluidics channel at 3 m/second, requiring frame rates greater than 500,000 frames per second (fps). The VEO 710 employs a custom complementary metal-oxide-semiconductor sensor with 7 Gpx/s image throughput and supports the fast offload of data, contributing to IntelliSep’s fast, 10-minute sample turnaround time. It is also a well-established camera used in a variety of industries and applications, with the proven reliability necessary for long-term success.
“Phantom VEO high-speed cameras provide valuable insights into many biological and biomedical events that are otherwise too fast to be seen,” said Toni Lucatorto, product manager, Vision Research. “They are a key enabling technology in flow cytometry, and we’re very excited to be part of this life-saving medical breakthrough.”
